Product image of Cevenfacta (Eptacog Beta (Activated)) supplied by GNH India

Cevenfacta

Active Ingredient:
Eptacog Beta (Activated)
Origin:
EU

Cevenfacta (Eptacog Beta (Activated))

Cevenfacta (Eptacog Beta) is a recombinant coagulation factor used for intravenous administration. It plays a role in blood clotting and is often utilized in specific medical conditions requiring coagulation support.

Manufacturer / TM Owner

Laboratoire Francais Du Fractionnement Et Des Biotechnologies

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Cevenfacta is primarily used to manage bleeding episodes in patients with certain coagulation disorders. It works by activating the coagulation cascade, which helps to form blood clots and stop bleeding. This medication is typically administered intravenously under medical supervision.

Side Effects

  • Common effects of Cevenfacta may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience systemic reactions like fever or chills. These effects are generally mild and transient, but any persistent or severe reactions should be reported to a healthcare provider.

Precautions & Warnings

  • Cevenfacta should be handled with care, ensuring proper storage and administration protocols are followed. It is essential to use this medication under the guidance of a healthcare professional to monitor for any adverse reactions. Patients with a history of allergic reactions to similar products should exercise caution.

Avoid Interactions

  • Cevenfacta may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Cevenfacta is used to manage bleeding episodes in patients with certain coagulation disorders by activating the coagulation cascade.

Cevenfacta is administered intravenously, typically under medical supervision.

Common side effects may include localized reactions at the injection site, such as redness or swelling, and systemic reactions like fever or chills.

Cevenfacta may interact with other medications that affect blood clotting, so it is important to consult a healthcare provider before combining treatments.

Patients with a history of allergic reactions to similar products should exercise caution and consult a healthcare provider before using Cevenfacta.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eptacog Beta (Activated)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT